Advances in Neuromodulation in Cancer Pain

7:00 AM - 8:00 AM Friday, January 14

While the mainstay of cancer pain management has been systemic opioids, many patients are unable to achieve analgesia with systemic opioids alone. Chemical neuromodulation, through intrathecal therapy, has played an important role in cancer pain management, and continues to evolve with new strategies for optimal management. Electrical neuromodulation, through spinal cord stimulation and peripheral nerve stimulation, is an emerging field of cancer pain management, with new approaches and new targets. In this session, we will discuss advances in both chemical and electrical neuromodulation for improving cancer pain management.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Understand the pharmacokinetics/pharmacodynamics of intrathecal therapy and impact on management of cancer pain
  • Comprehend different intrathecal therapy dosing strategies for management of cancer pain
  • Identify different targets for peripheral nerve stimulation for cancer pain
  • Appreciate the potential value of spinal cord stimulation for cancer pain management
Faculty:

David Copenhaver, MD;

Ann C. Shah, MD;

Sanjeet Narang, MD;

Tammy L. Dann, DO,MPH;

Scott Pritzlaff, MD;

Amitabh Gulati, MD;